The phrase "a reduction in intestinal" is correct and usable in written English.
It can be used in contexts discussing health, biology, or medical conditions where a decrease in intestinal function or size is relevant.
Example: "The study found a significant reduction in intestinal absorption rates among the participants."
Alternatives: "a decrease in intestinal" or "a decline in intestinal".
The implications of such effects may be manifold including, but not limited to, (a) reduction in intestinal pathogenic burden, (b) reduced concentrations of toxins in the gut microenvironment, and/or (c) reduced systemic spread of the pathogen, all subsequently resulting in reduced disease manifestation.
9, 10 Conversely, deficiency/insufficiency of vitamin D causes a decrease in the serum concentration of calcium due to a reduction in intestinal absorption of calcium.
As a consequence of maldigestion and inflammatory changes of the bowel mucosal membrane secondary to SIBO, patients experience a reduction in intestinal absorption.
Some clinical trials, in which mesenteric blood flow was recorded directly, demonstrated a reduction in intestinal perfusion, which was not corrected with the administration of intravenous fluids alone.
It has been suggested that individuals taking antibiotics were more likely have a reduction in intestinal bacteria, allowing Candida to opportunistically grow, thus resulting in an increase in intestinal Candida counts [ 22] which would support this observed association.
24 The biological basis for the growth-promoting effects of oral antibiotics could be a reduction in intestinal microflora, which compete for nutrients, 25 or treatment of subclinical infection.
Changes in gallbladder and intestinal fluorescence detected in the primary screening assay detected could have arisen from a reduction in either intestinal and or hepatic lipid processing.
A reduction in small intestinal CYP 3A levels by 60% was found to yield the best results, with simulated nifedipine concentration-time profiles within 20% of the in vivo observed results.
Interestingly, Roberts et al. reported that Apcmin/+ mice carrying an EGFR mutation with a marked reduction in EGFR activity had a 90% reduction in intestinal tumor compared with Apcmin/+ mice expressing normal EGFR [ 31].
The metabolic alterations in Eps8 knockout mice correlated with a significant reduction in intestinal fat absorption presumably caused by a 25% reduction in intestinal microvilli length.
As illustrated in Figure 2, HS caused a marked reduction in intestinal blood flow.
